Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Bone Marrow Transplantation|July 31, 2024
Mobilization strategies with and without plerixafor for autologous stem cell transplant in patients with multiple myelomaZachary M Avigan, Suzanne Arinsburg, Darren Pan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 8, 2013
A phase I study of CPX-351 in combination with busulfan and fludarabine conditioning and allogeneic stem cell transplantation in adult patients with refractory acute leukemiaUsama Gergis, Gail Roboz, Tsiporah Shore, et al.
Targeted Oncology|March 13, 2026
First-in-Human Phase I Study of KPT-9274, a First-in-Class Dual Inhibitor of PAK4 and NAMPT, in Patients with Advanced Solid MalignanciesAlbiruni Razak, Amit Mahipal, Jennifer R Diamond, et al.
Blood Advances|May 23, 2020
Adult cord blood transplant results in comparable overall survival and improved GRFS vs matched related transplantPrashant Sharma, Enkhtsetseg Purev, Bradley Haverkos, et al.
Journal of Clinical Medicine|February 26, 2025
Impact of Prior Selinexor Exposure on Outcomes of Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma: An Exploratory AnalysisBruno Almeida Costa, Danai Dima, Tomer Mark, et al.
Leukemia & Lymphoma|December 11, 2007
Prophylactic low-dose aspirin is effective antithrombotic therapy for combination treatments of thalidomide or lenalidomide in myelomaRuben Niesvizky, Déborah Martínez-Baños, Jessica Jalbrzikowski, et al.
Ejhaem|June 8, 2026
Single-Agent Selinexor Versus Physician's Choice in Previously Treated Myelofibrosis: Results From the Phase 2 XPORT-035 StudySebastian Grosicki, Habte Yimer, Rosa Ayala, et al.
Leukemia & Lymphoma|June 24, 2016
Cord blood chimerism and relapse after haplo-cord transplantationKoen van Besien, Nebu Koshy, Usama Gergis, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 31, 2016
Allogeneic Transplantation for Patients With Advanced Myelofibrosis: Splenomegaly and High Serum LDH are Adverse Risk Factors for Successful EngraftmentUsama Gergis, Emil Kuriakose, Tsiporah Shore, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 11, 2008
Stem cell mobilization with cyclophosphamide overcomes the suppressive effect of lenalidomide therapy on stem cell collection in multiple myelomaTomer Mark, Jessica Stern, Jessica R Furst, et al.
Pageof 4